跳至主要内容
临床试验/NCT03811613
NCT03811613已完成不适用

Photobiomodulation in Parkinson´s Disease: A Randomized Controlled Trial.

University of Oviedo4 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2018年1月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
4
主要终点
The motor portion of the MDS-UPDRS.

研究概览

简要总结

This study aimed to assess the effects of transcranial photobiomodulation in patients with Parkinson's disease (PD).

详细描述

Thirty-five patients with idiopathic PD were randomly assigned to a photobiomodulation (n=17, [mean±SD] 72±7 years) or sham group (n=18, 70±8 years) during 9 weeks (2 sessions/week). The primary endpoint was the motor portion of the Movement Disorders Society-United PD Rating Scale. Secondary endpoints were the Scales for Outcomes in PD, static posturography, walking ability (ten-meter walk test [TMWT]) and functional mobility (timed up and go [TUG] test).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Having been diagnosed with idiopathic PD.
  • Stage 1-2 on the Hoehn and Yahr Scale.
  • Having no neurological condition other than PD.
  • Being able to stand for 2 minutes and walk 10 meters without assistance.
  • Having no severe dyskinesias or "ON-OFF" phases.

排除标准

  • Do not follow inclusion criteria.

研究组 & 干预措施

Photobiomodulation group

Experimental

17 Parkinson´s disease patients were randomly assigned to the photobiomodulation group (experimental group).

Intervention: Photobiomodulation was administered using red light-emitting diodes (LEDs) with a 670-nm wavelength in six 1-minute blocks alternating the LEDs between the right and left temples, with a 30-second rest between blocks.

干预措施: Transcranial photobiomodulation (Other)

Sham group

Sham Comparator

18 Parkinson´s disease patients were randomly assigned to the sham group.

Intervention: Procedures for the sham group were identical as the photobiomodulation one, except that patients received photobiomodulation during only 5 seconds followed by 55 seconds with no treatment (equalling 1/12th of the energy used for the intervention group).

干预措施: Transcranial photobiomodulation (Other)

结局指标

主要结局

The motor portion of the MDS-UPDRS.

时间窗: 9 weeks

The motor portion (part III) Movement Disorders Society-Unified PD Rating Scale. It assesses the motor signs of Parkinson´s disease (minimum and maximum score is 0 and 76 points respectively -the higher score, the higher movement disorder and vice versa-).

次要结局

  • Motor function(9 weeks)
  • Static posturography(9 weeks)
  • Walking speed(9 weeks)
  • TUG(9 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Luis Santos

Principal Investigator

University of Oviedo

研究点 (4)

Loading locations...

相似试验